Home About Changzhou Mayor’s Mailbox Government Bulletin Latest News Laws and Regulations Living in Changzhou Investment Guide
Yangtze River Pharm launches a 5 billion program in Changzhou
Font:〖L M S

On Nov 19, the program of Jiangsu Hailang Co., Ltd., with a total investment of 5 billion RMB by Yangtze River Pharmaceutical Group, was launched in Changzhou National Hi-Tech District (CND). Ding Chun, mayor of Changzhou, and Zhou Bin, secretary of the CPC Working Committee of CND, attended the groundbreaking ceremony.

Yangtze River Pharm has maintained good cooperation with CND since 2001 when the group established Zilong Pharmaceutical Co., Ltd. here in Changzhou. The company’s workshops producing small volume injections and freeze-dried powder injections have been authenticated by the new version of GMP 2015. The newly launched program will robustly drive CND’s development of new medicine and medical device industries.

Jiangsu Hailang Co., Ltd. is located in the Health Industrial Park, mainly involved in the R&D, manufacturing and sales of anti-tumor medicines, suspensions, oral solution, solid preparations, medical equipment and other products. After the design capacity is achieved, the annual sales volume is expected to exceed 10 billion RMB.

Up to now, CND has gathered more than 120 biomedicine and related enterprises which are mostly located in the Health Industrial Park. Among them, 15 enterprises each has reached output value of 100 million RMB. A number of well-known enterprises like Qianhong Biochemical and Fangyuan Pharmacy are playing a leading role in the productions of enzymes and polysaccharides medicines in China.

Sponsored by: General Office and Foreign Affairs Office of Changzhou Municipal People’s Government
All rights reserved.Jiangsu ICP Record No. 05003616
Best viewed in IE 6.0 browser with and above 1024*768 resolution.